Ketan C. Ruparelia - Concepedia

Author

Ketan C. Ruparelia

Also Known As

K C Ruparelia, K Ruparelia, K. C. Ruparelia, K. Ruparelia, Ketan C. Rupareila, Ketan C. Ruparelia, Ketan Ruparelia, Ruparelia, Ketan C., Zeka, Keti, K Ruparelia

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

De Montfort University University of Leicester University of Crete University of L'Aquila University of Bologna

About

Ketan C. Ruparelia is an author at De Montfort University specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	650
2	Natural Sciences	5	5	289
3	Biochemistry	4	4	367
4	Engineering	3	3	63
5	Health Sciences	2	2	157

Ketan C. Ruparelia

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1 Gerard A. Potter, L. H. Patterson, E Wanogho, British Journal of Cancer	2002	372
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene S. Sale, Richard D. Verschoyle, David J. Boocock, British Journal of Cancer	2004	259
Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog <i>trans</i> 3,4,5,4′‐tetramethoxystilbene (DMU‐212) on adenoma development in the Apc<sup><i>Min+</i></sup> mouse and cyclooxygenase‐2 in human‐derived colon cancer cells Stewart Sale, Richard Tunstall, Ketan C. Ruparelia, International Journal of Cancer	2005	165
Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes Keti Zeka, Ketan C. Ruparelia, Randolph Arroo, Diseases Metabolic SyndromeDietary FlavonoidsBiochemistryMedicineNovel Drug Candidates	2017	143
Petals of Crocus sativus L. as a potential source of the antioxidants crocin and kaempferol Keti Zeka, Ketan C. Ruparelia, Maria Adelaide Continenza, Fitoterapia BotanyBiochemistryMedicineNatural SciencesPhysiology	2015	130
CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells Vasilis P. Androutsopoulos, Ketan C. Ruparelia, Randolph Arroo, Toxicology Dietary FlavonoidsMedicineCyp1-mediated Antiproliferative ActivityBreast CancerPhytochemical	2009	95
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation Elshaimaa Sayed, Christina Karavasili, Ketan C. Ruparelia, Journal of Controlled Release	2018	76
Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: Structural requirements for potency Vasilis P. Androutsopoulos, Ketan C. Ruparelia, Athanasios Papakyriakou, European Journal of Medicinal Chemistry Medicinal ChemistryPolyphenolicsResveratrol AnalogueBiochemistryStructural Requirements	2011	57
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines Neill Horley, Kenneth J. M. Beresford, Tarun Chawla, European Journal of Medicinal Chemistry Medicinal ChemistryMedicineNatural SciencesRational Drug DesignMolecular Biology	2017	51
Flavones as tyrosinase inhibitors: kinetic studies <i>in vitro</i> and <i>in silico</i> Randolph Arroo, Burak Barut, Arzu Özel, Phytochemical Analysis	2020	42

Page 1